Adam Pascale

2016

In 2016, Adam Pascale earned a total compensation of $235.4K as CFO at Hemispherx Biopharma, a 22% increase compared to previous year.

Compensation breakdown

Option Awards$12,590
Salary$190,767
Other$32,037
Total$235,394

Pascale received $190.8K in salary, accounting for 81% of the total pay in 2016.

Pascale also received $12.6K in option awards and $32K in other compensation.

Rankings

In 2016, Adam Pascale's compensation ranked 13,164th out of 14,075 executives tracked by ExecPay. In other words, Pascale earned more than 6.5% of executives.

ClassificationRankingPercentile
All
13,164
out of 14,075
7th
Division
Manufacturing
5,139
out of 5,486
6th
Major group
Chemicals And Allied Products
1,810
out of 1,900
5th
Industry group
Drugs
1,473
out of 1,543
5th
Industry
Biological Products, Except Diagnostic Substances
270
out of 287
6th
Source: SEC filing on July 18, 2017.

Pascale's colleagues

We found three more compensation records of executives who worked with Adam Pascale at Hemispherx Biopharma in 2016.

2016

Thomas Equels

Hemispherx Biopharma

Chief Executive Officer

2016

David Strayer

Hemispherx Biopharma

Chief Scientific Officer

2016

Peter Rodino

Hemispherx Biopharma

General Counsel

News

You may also like